Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disordered Bleeding in Ehlers Danlos Syndromes

NCT05434728 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05434728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05434728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disordered Bleeding in Ehlers Danlos Syndromes
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2022
Completion date
February 1, 2024
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

classical eds (ceds), classical ehlers-danlos syndrome, eds, ehlers-danlos syndrome, hypermobile eds (heds), hypermobile ehlers-danlos syndrome, vascular eds (veds), vascular ehlers-danlos syndrome